395069-17-7

Upstream product

• 244777-34-2 (3S,4S)-3-tert-butyldiphenylsilyloxy-4-triisopropylsilyloxymethylazetidin-2-one 
• 244777-33-1 (3S,4S)-3-tert-butyldiphenylsilyloxy-4-hydroxymethylazetidin-2-one 
• 244777-36-4 (2S,3S,5RS)-2-tert-butoxycarbonylamino-3-tert-butyldiphenylsilyloxy-5-p-tolylsulfonyl-1-triisopropylsilyloxyoctadecan-4-one 
• 244777-35-3 (3S,4S)-N-tert-butoxycarbonyl-3-tert-butyldiphenylsilyloxy-4-(triisopropylsilyloxy)methylazetidin-2-one 
• 95049-19-7 4-tolyl tetradecylsulfone 
• 112-71-0 1-Bromotetradecane 
• 13154-24-0 triisopropylsilyl chloride 
• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 
• 244777-37-5 (2S,3S)-2-tert-butoxycarbonylamino-3-tert-butyldiphenylsilyloxy-1-triisopropylsilyloxyoctadecan-4-one 

Downstream Products

• 116467-63-1 N-tert-butyloxycarbonylsphingosine 
• 1026601-72-8 [2-(tert-butyl-diphenyl-silanyloxy)-1-triisopropylsilanyloxymethyl-heptadec-3-enyl]-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

Stereoselective synthesis of D-erythro-sphingosine and L-lyxo-phytosphingosine

An alternative synthetic route to D-erythro-sphingosine and L-lyxo-phytosphingosine was developed, utilizing chiral β-lactam 3 obtained from D-(-)-tartaric acid as a starting material.

An alternative synthesis of D-erythro-sphingosine and L-lyxo-phytosphingosine

Chiral β-lactam 1 obtained from D-(-)-tartaric acid was converted to a D-erythro-sphingosine equivalent 7 in 35% yield, without yielding a 4Z-geometrical isomer, and L-lyxo-phytosphingosine 8 in 45% yield, respectively.